Bio-Techne said on Thursday that it has released data analysis software for Luminex xMAP instruments.
Its Quantist software provides researchers with a tool for analyzing dozens of analytes with improved accuracy and efficiency, including the ability to evaluate the long-term consistency of their Luminex assay data, Bio-Techne said.
The intuitive software interface allows users to make interassay comparisons, adjust standard curve parameters, and export optimized data for creating ready-to-graph Excel files, Bio-Techne added.
Luminex xMAP technology is a bead-based assay platform that allows for the simultaneous detection of multiple targets in a single sample.
Austin, Texas-based Luminex was acquired by Saluggia, Italy-based DiaSorin for $1.8 billion in 2021.